Should healthy people be screened for narrowed neck arteries?

If you have no symptoms and no history of stroke, the US Preventive Services Task Force recommends against being screened for narrowing of the carotid arteries in the neck — a Grade D recommendation, meaning the harms outweigh the benefits [s1]. That verdict, reaffirmed in 2021 and unchanged since 2014, is aimed squarely at the walk-in "vascular screening" ultrasound that healthy people are sometimes offered, and it rests on an unglamorous chain of reasoning about false alarms and risky surgery [s1].

What is being screened for

The carotid arteries carry blood to the brain, and when atherosclerotic plaque narrows them — carotid artery stenosis — it can, in principle, throw off clots that cause a stroke. That makes screening sound obviously worthwhile. But two facts undercut it. First, in people without symptoms the condition is uncommon: the general-population prevalence of carotid stenosis is only about 0.5% to 1% [s1]. Second, although stenosis is a stroke risk factor, it causes only a relatively small share of strokes, most of which come from other mechanisms [s1].

Screening is usually done with carotid duplex ultrasonography, sometimes preceded by a doctor listening for a bruit — a whooshing sound over the artery. Listening is close to useless for this: the Task Force notes that auscultation for carotid bruits has poor accuracy [s1].

Why a good-sounding test fails

The problem is arithmetic that recurs across screening. When a test is applied to a population in which almost no one has the disease, even a fairly accurate test produces mostly false alarms. The Task Force's evidence review found carotid ultrasound had a wide range of performance — sensitivity of 46% to 77% and specificity of 71% to 98% — and that screening the general population, where stenosis is rare, generates many false-positive results [s1].

A false positive is not harmless here, because of what comes next. Confirming or acting on a positive scan leads toward angiography and, potentially, surgery to open the artery — carotid endarterectomy or stenting — and those procedures carry their own risk of causing the very stroke they aim to prevent. In a meta-analysis of trials (5,223 patients), 1.9% more patients treated with surgery than with medical therapy alone had a stroke or died within 30 days of the operation (95% confidence interval, 1.2% to 2.6%) [s1]. Those trials were also run before modern drug therapy — statins and blood-pressure control — narrowed the gap further, so any surgical benefit in today's asymptomatic patients is likely smaller than the old numbers imply [s1].

Weighing the low yield, the false positives and the surgical hazard, the Task Force concluded with moderate certainty that the harms of screening outweigh the benefits, and that there is inadequate direct evidence that screening asymptomatic people reduces strokes or deaths at all [s1].

Where the guidance diverges

This is not a case of one authority against the field. The Society for Vascular Surgery — the specialists who perform these operations — reached a compatible but more permissive position in its 2021 guidelines [s2]. It agrees that screening the general population without symptoms or significant risk factors is not recommended [s2]. But it suggests screening selected asymptomatic patients at increased risk of carotid stenosis, provided they would be fit for and willing to consider a procedure if a significant narrowing were found [s2].

That is the real boundary of the debate. Both bodies reject the blanket scan sold to the worried well; they differ on whether a defined higher-risk subgroup — for instance, people with widespread atherosclerosis — should be looked at. Neither endorses the direct-to-consumer "stroke screening" package, and the case against it is the same one the Task Force makes: searching a low-risk person for a rare narrowing mostly finds false alarms and paths to treatment that can hurt.

What it means for a reader

For someone healthy and without symptoms, the evidence points against seeking out a carotid scan, whatever a mailer or a health-fair booth suggests [s1]. This is different from ignoring warning signs: sudden weakness, trouble speaking, facial droop or vision loss are reasons to seek emergency care, not screening. Carotid screening sits alongside other tests where the honest finding is that looking harder does not help the average person — a pattern also visible in the debate over whole-body skin cancer screening and in what imaging reveals about silent atherosclerosis in people with no symptoms.